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in residential facilities for older people suggests
how to improve quality
Karla Diaz-Ordaz1,2*, Robert Froud1,3, Bart Sheehan4 and Sandra Eldridge1Abstract
Background: Previous reviews of cluster randomised trials have been critical of the quality of the trials reviewed,
but none has explored determinants of the quality of these trials in a specific field over an extended period of
time. Recent work suggests that correct conduct and reporting of these trials may require more than published
guidelines. In this review, our aim was to assess the quality of cluster randomised trials conducted in residential
facilities for older people, and to determine whether (1) statistician involvement in the trial and (2) strength of
journal endorsement of the Consolidated Standards of Reporting Trials (CONSORT) statement influence quality.
Methods: We systematically identified trials randomising residential facilities for older people, or parts thereof,
without language restrictions, up to the end of 2010, using National Library of Medicine (Medline) via PubMed
and hand-searching. We based quality assessment criteria largely on the extended CONSORT statement for cluster
randomised trials. We assessed statistician involvement based on statistician co-authorship, and strength of journal
endorsement of the CONSORT statement from journal websites.
Results: 73 trials met our inclusion criteria. Of these, 20 (27%) reported accounting for clustering in sample size
calculations and 54 (74%) in the analyses. In 29 trials (40%), methods used to identify/recruit participants were
judged by us to have potentially caused bias or reporting was unclear to reach a conclusion. Some elements of
quality improved over time but this appeared not to be related to the publication of the extended CONSORT
statement for these trials. Trials with statistician/epidemiologist co-authors were more likely to account for clustering
in sample size calculations (unadjusted odds ratio 5.4, 95% confidence interval 1.1 to 26.0) and analyses (unadjusted
OR 3.2, 1.2 to 8.5). Journal endorsement of the CONSORT statement was not associated with trial quality.
Conclusions: Despite international attempts to improve methods in cluster randomised trials, important quality
limitations remain amongst these trials in residential facilities. Statistician involvement on trial teams may be more
effective in promoting quality than further journal endorsement of the CONSORT statement. Funding bodies and
journals should promote statistician involvement and co-authorship in addition to adherence to CONSORT guidelines.
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In cluster randomised trials, groups (or clusters) of in-
dividuals are randomised, rather than the individuals
themselves. Over the past 25 years this trial design has
become increasingly common in many fields such as
primary care, where the clusters are often general practices
(because the target of an intervention is a practice or
its staff ), and in low-income countries (where villages
or geographic areas are often randomised to avoid con-
tamination between intervention and control group
participants in the same village/area). These trials are
more complicated than individually randomised trials
to design, conduct and analyse. In particular, sample
size calculations and analyses should be adjusted to
allow for homogeneity of individuals in the clusters, and
investigators must avoid potential bias when identifying
and recruiting individual participants [1-4]. Previous
reviews of these trials indicate low quality in respect of
these and other methodological and reporting criteria
[4-12], and a possible trend from comparing review results
of quality improvement over time [4]. Only one previous
review explores trends in and determinants of quality
directly [12], finding generally higher quality in journals
with higher impact factors, but only modest impact of
the 2004 extended CONSORT statement for cluster
randomised trials [13]. In that paper, the authors suggest
that it may require more than publication of guidelines
to assist editors and investigators in the correct conduct
and reporting of these trials. Elsewhere it has been
hypothesised that pressure from statisticians may have
contributed to improvements in the quality of these trials
[9]. Whilst there is no empirical evidence to support
this, there is evidence for the effect of the presence of
statisticians on the quality of individually randomised
trials [14,15]. Previous research has identified better
reporting amongst randomised controlled trials published
in journals more strongly promoting the 1996 original
CONSORT statement [16].
We were aware of several cluster randomised trials
evaluating a range of interventions in residential facilities
for older people [17,18]. We reasoned that these trials
should be common in such facilities because of the types
of intervention likely to be evaluated such as changing
treatment policies, and because of the risk of contamination
between individuals living in such close proximity even
when an individually randomised trial might have been
possible in other settings. There are no previous reviews
of trials in this area; we therefore expected quality to be
more variable than in areas where the publication of
reviews may have influenced conduct and reporting.
There are ageing populations worldwide and even the
most optimistic projections for community focused
care suggest that the proportion of over 65s that can
expect to receive long-term care in residential facilitieswill increase [19,20] beyond current levels. About a half
are currently in long-term care [21,22]. The quality of
cluster randomised trials in care homes is therefore
important for shaping future healthcare evidence [23].
Here we describe the characteristics, and quality of
methods and of reporting, of cluster randomised trials in
residential facilities and provide some practical guidance for
future investigators that could facilitate faster improvement
in trial design, conduct and analysis, and thus accelerate an
increase in the quantity of high quality research in this
area. In particular, we wanted to see whether statistician
involvement in the trial, and the strength of a journal’s
endorsement of the CONSORT statement affected the
methodological and reporting quality.
Methods
Inclusion and exclusion criteria
We included cluster randomised trials conducted up to
the end of 2010 in residential facilities for older people
where the unit of randomisation was the facility or a
physical part of it, for example a ward, wing, or floor.
We used the Medical Subject Headings definition of
residential care facilities: long-term care facilities which
provide supervision and assistance in activities of daily
living with medical and nursing services when required. We
extended this definition to other group-living arrangements
where some care is provided, for example, retirement
villages. The majority of the residents included in a trial
had to be over the age of 60. We excluded quasi-
experimental cluster designs, studies reported as ‘pilot’,
‘feasibility’, or ‘preliminary’ studies, studies in which no
outcomes were reported, and reports on cost-effective-
ness. No studies were excluded on the basis of quality,
since our aim was to provide a description of quality. No
trial was excluded on the basis of language or date of pub-
lication. Following the example of a previous review [24],
secondary reports of individual trials were included if they
reported different outcomes from the primary report.
Data sources and search methods
We searched PubMed for relevant reports in early 2011.
The full electronic search strategy is given in (Additional
file 1: Box 1). KDO hand-searched the electronic archives
of journals identified from initial scoping searches as those
publishing at least five potentially relevant papers: the
British Medical Journal, Journal of the American Medical
Association, BioMed Central Health Services Research, Age
and Ageing and the Journal of the American Geriatrics
Society, back to the year 2000. We also conducted
citation searches of each eligible report identified to find
additional eligible trial reports. Finally, we contacted
authors identified from the searches as having published
at least three primary reports of trials in the area, asking
them to identify additional studies.
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The validation process was defined in the protocol as
consisting of an independent reviewer assessing the
eligibility of papers that turn up in the searches strictly
following the inclusion criteria without prior knowledge of
the decision made by the lead reviewer as to the suitability
of the paper.
To validate hand and citation searches performed by
KDO, RF hand-searched the electronic version of the
Journal of the American Geriatric Society for 2004, the
Journal of the American Medical Association for 2000,
and the references of two included papers [25,26].
KDO examined titles and abstracts of trials identified
from electronic searches and obtained full texts, of those
definitely or possibly satisfying inclusion criteria. To
validate, RF carried out the same process on a random
10% selection of the electronically identified trials, a
validation method used by previous reviews of this type
[10]. When it was unclear from full texts whether a trial
should be included, a final decision was made by SE.Data extraction
KDO extracted data from all reports; SE or RF completed
a second, independent, extraction for every report. Dis-
crepancies were resolved by discussion. We used written
guidance, agreed in advance of any extractions, when
extracting data. Data were extracted onto a front-end
program developed by us to assist consistency of recording
and field completion in the data extraction process and
to transfer extracted data to a spreadsheet. We included
relevant data reported in trial protocols and other publica-
tions when these were clearly referenced in the main
publication.Data extracted
To describe the trials, we extracted data on publication
date, country (or countries) in which the trial was set
and one primary outcome per report, defined as that
specified by the authors, or if not specified, the outcome
used in sample size calculations. If no primary outcome
was specified and no sample size calculation was reported,
the first outcome presented in the abstract was considered
primary. We divided the primary outcomes into broad
categories, for example: use of restraint, falls, depression,
or medication use.
To assess the quality of trials, we created a list of quality
items based on the extended CONSORT statement for
cluster randomised trials [13], items included in previous
methodological reviews [3,4,27] and decisions by our
team. See (Additional file 1: Table A).
To classify the potential for identification/recruitment
bias resulting from lack of blinding of those identifying
or recruiting potential participants, we used a graphicalaid previously published [27], based on the definitions
used by Eldridge et al. [4].
To investigate the effect of the strength of the journal’s
endorsement of the extended CONSORT statement on
quality, in early 2011, KDO and RF independently extracted
all relevant text referring to the statement from the online
versions of the ‘Instructions to authors’ of journals in which
trial reports from 2005 onwards (after the publication of
the extended CONSORT statement) were published. We
adapted a previously used scale to classify journals as
having high endorsement of the CONSORT statement
[28,29]. If the journal website used the words ‘required’,
‘must’, ‘should’, or ‘strongly encouraged’ in relation to ad-
herence to the CONSORT checklist, medium endorse-
ment if the website used the words ‘encouraged’ or
‘recommended’ or ‘advised’ or ‘please’, and low en-
dorsement if the website used words such as ‘may wish
to consider’ or ‘see CONSORT’ or there was no men-
tion of the CONSORT statement.
We used statistician co-authorship as an indication of
active statistician involvement. Based on a previously
used criterion [15,30], we considered the report as having
a statistician (or an epidemiologist or other quantitative
methodologist) as co-author if at least one of the authors
listed in the report belonged to a department/unit of
biostatistics/epidemiology or mathematical sciences or
was clearly designated as a statistician/epidemiologist.
KDO and SE independently reviewed declared affiliations
and qualifications in trial reports and when these were
not clearly reported searched the web for affiliations
and qualifications of authors; when it was impossible to
ascertain whether or not there was a statistician as co-
author, this was recorded as missing. To minimise bias,
we conducted these reviews separately from the main
data extraction.
KDO and RF piloted the full inclusion and extraction
process on a 10% sample of reports identified by electronic
searches and hand searching. We refined the protocol
accordingly and it is available from the authors.
Analysis
We present descriptive statistics on trial characteristics, and
describe examples of some common types of intervention.
For each quality criterion, we present the overall percentage
adhering to relevant recommendations. To explore reasons
for variation in quality we also present these percentages
by whether the trial was published in 2004 (when the first
extended CONSORT statement for cluster randomised
trials was published) or earlier, or after 2004; by whether
the trial had statistician involvement or not; and for those
trials published after 2004, by the strength of the journal’s
endorsement of the CONSORT statement. To avoid diffi-
culties in interpreting multiple comparisons in the context
of a small sample size, we conducted formal statistical
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CONSORT endorsement, statistician involvement, and
publication period for three key methodological quality
indicators selected from the methodological literature
[14,31,32] and in consultation with three experts in the
field. These were ‘reported accounting for clustering in
sample size calculations’, ‘reported accounting for clustering
in analysis’ and ‘low or no potential for selection bias’.
They reflect the major issues affecting the validity of
cluster randomised trials, as failing to account for clustering
in the sample size may result in loss of power to detect
statistically significant differences, not accounting for
clustering in the analysis results in a higher risk of a
Type I error (i.e., erroneously concluding there was a
statistically significant difference), and selection bias
may be present since cluster randomised trials often
recruit their participants after the clusters have been
randomly allocated to treatment [3,4].
We conducted univariable and multivariable logistic
regression accounting for statistician co-authorship, publi-
cation period, and a variable with four categories (pub-
lication up to 2004, publication after 2004 and low
CONSORT endorsement by journal, publication after
2004 and medium CONSORT endorsement, publication
after 2004 and high CONSORT endorsement) thatFigure 1 Flow diagram of the identification process for the sample ofcombined publication period and journal CONSORT
endorsement. We conducted all analyses using Stata
release 11 [33].
Results
We identified 308 published reports via our electronic
search, rejecting 248 on the basis of titles or abstracts
(56 non-randomised studies, 68 individually randomised
trials, 95 cluster randomised trials either not in residen-
tial facilities for older people or in such facilities but
randomising units other than the facility or a part of a
facility, 21 protocols and other reports with no results,
seven pilot or feasibility studies, one cost-effectiveness
study). Additionally, 11 reports were found by hand
searching (corresponding to references [A12, A14, A20,
A26-A28, A45, A48, A50, A78, A83], Additional file 1),
16 by searching the references of included reports, and
three from experts (references [A30, A68, A69], see
Additional file 1), making a total of 90 full-text papers to
be examined (Figure 1).
From these, 73 primary [A1-A73, A78] and 11 sec-
ondary reports [A74-A84] met our eligibility criteria
(see Additional file 1: Tables B and C). Fifty-five had
been identified by our electronic search. The full reference
list is reported in the Appendix (reference numbers are73 cluster randomised trials included in this review.
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reference list in the Additional file 1).
There was 93% agreement between the two reviewers
for the 10% random sample used for the electronic
search sifting validation (based on 31 reports), with a
Cohen kappa coefficient of 0.87. The reviewers agreed
on 100% of the hand-searches.
Trial characteristics and interventions
Of the 73 included trials, over half were conducted in
North America or the UK (Table 1). The number of
clusters randomised ranged from three [A45] to 223
[A55] and the number of individuals included in the
analysis from 41 [A3] to 6636 [A73]. There were 68
parallel trials, two with factorial designs [A38, A50],
four cross-over trials [A27, A28, A45, A48], and one
split-plot design where each individual acted as his orTable 1 Characteristics of trials
Characteristic Number of trials (%)
Publication year
1992-2004 29 (40)
2005-2010 44 (60)
Country
USA 17 (23)
UK 16 (22)
Netherlands 9 (12)
Canadaa 7 (10)
Australia 5 (7)
Sweden 5 (7)
Others 14 (19)
Number of clusters
randomised
Median (IQR) 15 (10, 36)
Range 3 to 230
Average cluster sizeb
Median (IQR) 26.2 (14.8, 42.9)
Range 3.2 to 201.1
Primary focus of research
(based on primary outcome)
Falls or fractures 21 (29)
Medication use 13 (18)
Quality of Life 13 (18)
Use of restraints 6 (8)
Respiratory 4 (6)
Depression 2 (3)
Other 14 (19)
a of which two jointly with the USA.
b Defined as number of individuals analysed/ number of clusters analysed, and
which had 17 missing values, because we couldn’t obtain either the number
of individuals or of clusters in the analysis.her own control [A44]; 27 trials (38%) were matched in
pairs and two in triplets, 18 (24%) were stratified and
the rest were randomised without any restrictions.
Interventions usually targeted staff in the facilities,
residents, or both, though a few targeted premises (for
example, modification of the residents’ environment).
Interventions aimed at staff were typically education and
training, or the provision of a tool such as a falls risk
assessment tool or a computerised decision support
system. Interventions aimed at residents were typically
treatments such as vaccines or hip protectors, or program-
mes of assessment and activity which often took place
over a period of time, aimed at, for example, increasing
mobility. See (Additional file 1: Box 2).
Trial quality
Quality was variable (Table 2). The word ‘cluster' was
used in the title or abstract in 51/84 (61%) reports. A
clustered design was explicitly justified in 30 primary
reports (42%) while the intervention in two further trials
involved changing the light fittings of the whole facility,
making individual allocation impossible [34,35].
Sample size calculations were described in 60% (43/73)
of primary reports; clustering was accounted for in 47%
(20/43) of these. Clustering was accounted for in the
primary analyses of 74% (54/73) of the trials. We assessed
recruitment/identification bias as ‘not possible’ in 36 trials
(49%), unlikely in 8 trials (11%), unclear in 24 trials (33%),
and possible in 5 trials (7%).
Many other quality criteria were reasonably well
reported, but few primary reports reported intra-cluster
correlation coefficients (eight trials) or mentioned adverse
events (17 trials). Information about individuals was better
reported than information about clusters. For example,
loss to follow-up of individuals was described in 53 reports
but loss to follow-up of clusters in only 28. Blinding of
primary outcome assessors was clearly reported in only
32 (44%) trials.
In extracting data, we identified further quality issues in
relation to the design of some trials. For example, authors
of four trials reported that contamination between inter-
vention arms may have occurred or indeed had occurred,
due to the randomisation of wards or floors within the
same residential unit to different intervention arms
[A53, A57, A72, A82]. Since one rationale for cluster
randomisation is to prevent contamination, its occurrence
within such trials suggests lack of adequate planning at
the design stage.
Determinants of quality
We included 44 primary reports published since 2005 in
22 journals, 15 in journals strongly endorsing CONSORT,
18 in journals with medium endorsement and 11 in
journals with low endorsement (See (Additional file 1:
Table 2 Number (proportion) of primary reports adhering to quality criteria by key characteristics
Criterion Total Publication year Statistician co-authored Strength of CONSORT endorsementc
N = 73 Before
2005
2005 or
later
No Yes Low Medium High
N = 22 N = 51 N = 11 N = 18 N = 15
N = 29 N = 44
Term ‘cluster’ included in title or abstract 44 (60) 10 (34) 34 (77) 7 (32) 37 (73) 7 (64) 15 (83) 12 (80)
Cluster design justified 30 (41) 11 (38) 19 (43) 9 (41) 21 (41) 4 (36) 8 (44) 7 (47)
Eligibility criteria reported for individuals 65 (89) 25 (86) 43 (98) 20 (91) 45 (88) 9 (82) 16 (89) 15 (100)
Eligibility criteria reported for clusters 44 (60) 17 (59) 28 (64) 13 (59) 31 (61) 5 (45) 10 (56) 12 (80)
Sample size calculation reported 43 (59) 14 (48) 29 (66) 8 (36) 35 (69) 6 (55) 11 (61) 12 (80)
Clustering accounted for in sample size calculation 20 (27) 4 (14) 16 (36) 2 (9) 18 (35) 4 (36) 5 (28) 7 (47)
Evidence of variation in cluster size considered 4 (6) 0 (0) 4 (9) 1 (4) 3 (6) 1 (9) 1 (6) 2 (13)
Restricted randomisation 50 (68) 18 (62) 32 (73) 15 (68) 35 (69) 10 (91) 12 (67) 10 (67)
Potential for None 36 (49) 14 (48) 22 (50) 12 (57) 24 (47) 7 (64) 8 (45) 7 (47)
identification/recruitment bias Unclear 24 (32) 13 (45) 11 (25) 9 (41) 15 (29) 2 (18) 4 (22) 5 (33)
Unlikely 8 (11) 1 (3) 7 (16) 0 (0) 8 (16) 2 (18) 4 (22) 1 (6)
Possible 5 (7) 1 (3) 4 (9) 1 (5) 4 (8) 0 (0) 2 (11) 2 (13)
Outcome assessor blind to allocation 32 (44) 12 (41) 20 (45) 9 (41) 23 (45) 6 (55) 7 (39) 7 (47)
Clustering accounted for in analysis 54 (74) 19 (66) 35 (80) 13 (59) 41 (80) 8 (73) 15 (83) 12 (80)
Numbers of clusters randomised reported 71 (97) 29 (100) 42 (95) 21 (95) 50 (98) 9 (82) 18 (100) 15 (100)
Reported baseline of individual characteristics 69 (95) 28 (97) 41 (93) 22 (100) 47 (92) 10 (91) 17 (94) 14 (93)
Baseline of cluster characteristics reported 27 (37) 7 (24) 20 (45) 4 (18) 24 (47) 5 (45) 10 (56) 6 (40)
P-values not calculated for individual baseline comparisons 41 (56) 16 (55) 25 (57) 9 (43) 32 (63) 2 (18) 13 (72) 10 (67)
Reported numbers of clusters analysedd 63 (86) 25 (86) 39 (89) 18 (81) 46 (90) 9 (82) 16 (89) 14 (93)
Reported numbers of individuals analysed 66 (90) 24 (83) 39 (89) 21 (95) 42 (82) 8 (73) 17 (94) 14 (93)
Intra-cluster correlation coefficient (ICC) from analysis reportede 8 (14) 1 (5) 7 (20) 1 (5) 7 (18) 0 (0) 4 (14) 4 (33)
Adverse events reported 17 (23) 5 (17) 12 (27) 3 (14) 13 (25) 4 (36) 4 (22) 9 (60)
c Only 44 reports; as this categorisation applies only to publications after 2004.
d Data taken from results tables if not explicit.
e There were 17 reports where ICC calculations were not applicable (given the aggregated nature of outcome) hence only 56 reports are considered.
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included a statistician or other quantitative methodologist
as a co-author. Statistician co-authorship and publication
period appeared to have stronger influences on quality
than strength of a journal’s endorsement of the CONSORT
statement (Table 2).
In univariable analyses (Table 3), trials with statisticians
as co-authors were more likely to account for clustering in
the analysis (unadjusted OR 3.2, 95% confidence interval
(CI) 1.2 to 8.5) and sample size calculation (OR 5.4, 95%
CI 1.1 to 26.0), but evidence for the effect of statistician
co-authorship on identification and recruitment bias was
inconclusive (OR 1.4, 95% CI 0.5 to 3.8). Trials published
after 2004 were more likely to account for clustering in
the sample size (unadjusted OR 3.6 95% CI 1.1 to 12.1)
but although the direction of estimates was consistent,
there was no evidence that publication period affected the
likelihood of either accounting for clustering in the ana-
lysis (unadjusted OR 1.3 95% CI 0.5 to 3.2) or identifica-
tion/recruitment bias (unadjusted OR 1.9 95% CI 0.7 to
4.7). There appeared to be little effect of journal endorse-
ment of the extended CONSORT statement on any of the
methodological quality markers. Few effects were statisti-
cally significant (at 5% level) in multivariable analyses
(Table 3).Table 3 Unadjusted and adjusted odds ratio of adhering to q
Proportion adhering to c
Reported accounting for clustering in analysis (includes secondary reports, 84
No statistician co-author 16/28
Co-author included statistician 44/56
Publication prior to 2005 22/33
Journal CONSORT endorsement lowf 9/14
Journal CONSORT endorsement mediumf 16/21
Journal CONSORT endorsement highf 12/16
Reported accounting for clustering in sample size (unique trials, 73 reports)
No statistician co-author 2/22
Co-author included statistician 18/51
Publication prior to 2005 4/29
Journal CONSORT endorsement lowf 4/11
Journal CONSORT endorsement mediumf 5/18
Journal CONSORT endorsement highf 7/15
Identification/recruitment bias is not possible or unlikely (unique trials, 73 re
No statistician co-author 12/22
Co-author included statistician 32/51
Publication prior to 2005 15/29
Journal CONSORT endorsement lowf 9/11
Journal CONSORT endorsement mediumf 12/18
Journal CONSORT endorsement highf 8/15
f Reference category is publication pre-2005.
g Adjusted for the other variables in the table.Discussion
This first review of cluster randomised trials in residential
facilities for older people shows that there is a large number
of cluster randomised trials in this field and that their qual-
ity, although variable, has improved over time. Reporting of
sample size calculations, processes for identification and
recruitment of individual residents, blinding of outcome as-
sessors, adverse events, intra-cluster correlation coefficient,
and cluster characteristics appear to have been particularly
poor. There is stronger evidence of the effect of the pres-
ence of a statistician (or other quantitative methodologist)
amongst co-authors, than of the strength of a journal’s
endorsement of CONSORT recommendations on the
methodological quality of the trials.
Strengths and limitations
We used rigorous searching and data extraction proce-
dures including focused hand-searching resulting in a
comprehensive overview of cluster randomised trials in
residential facilities for older people. That almost one-
third of trials were not found using our electronic search
probably reflects poor reporting. Although our search
strategy compares favourably with one recently reported
with excellent sensitivity [36], we are aware that we may
have missed some cluster randomised trials in nursinguality criteria
riteria Unadjusted odds ratio Adjustedg odds ratio
reports)
Reference category
3.2 (1.2,8.5) 3.1 (1.1,8.7)
Reference category
0.9 (0.2,3.3) 0.8 (0.2,3.3)
1.6 (0.5,5.5) 1.1 (0.3,4.2)
1.5 (0.4,5.8) 1.4 (0.3,6.5)
Reference category
5.4 (1.1,26.7) 2.7 (0.5,16.2)
Reference category
3.6 (0.7,18.0) 3.5 (0.6,18.8)
2.4 (0.5,10.5) 1.7 (0.4,7.7)
5.5 (1.3,23.6) 4.7 (1.0,21.8)
ports)
Reference category
1.4 (0.5,3.9) 1.3 (0.4,4.0)
Reference category
4.2 (0.8,22.9) 4.1 (0.8,22.7)
1.9 (0.5,6.3) 1.8 (0.5,6.4)
1.1 (0.3,3.7) 10.2 (0.3,4.5)
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only five journals and hand searching provided a third of
our sample.
The size of our sample may be too small to detect some
associations, and results must be interpreted accordingly.
Our methods for identifying whether a statistician was
part of the writing team extended those previously used
[15,30], by incorporating a web-search of all authors in
the report. A possible limitation of our study is that jour-
nal instructions may not have been the same when trial
reports were actually published (between 2005 and 2010)
as they were when we extracted information on journals’
endorsements of the extended CONSORT statement in
2011.
Our assessment of quality was based only on informa-
tion in trial reports. Space limitations in journals may
sometimes preclude reporting of some factors relevant to
quality in published reports, although this may change
with increasing on-line publishing. Although there is no
stated consensus on the most important quality items,
the quality criteria we used are largely a subset of the
CONSORTchecklist, and we sought expert opinion before
choosing the specific methodological quality items to for-
mally analyse. The updated extension to the CONSORT
statement for cluster randomised trials [37], which was
published after we completed this review, acknowledges
the importance of considering two issues we include in
this review: the effect of variable cluster size on sample
size calculations and expands on item 10 to recommend
specific reporting of the way in which individuals are
included in the trial.Table 4 Percentages accounting for clustering in sample size
Authors Source of trials
Donner et al. [5] 16 non-therapeutic Intervention trials
Simpson et al. [6] 21 trials from Amer J Pub Health Prev Med
Chuang et al. [7] 24 trials of computer based decision support
Isaakidis et al. [8] 51 trials in Sub-Saharan Africa
Puffer et al. [3] 36 trials in BMJ, Lancet and NEJM
Eldridge et al. [10] 152 trials in primary health care
Varnell et al. [39] 60 trials in Amer J PubHealth Prev Med
Bland [9] 18 articles in BMJ
Eldridge et al. [4] 34 articles in primary health care
Murray et al. [38] 75 trials in oncology
Bowater et al. [11] 35 trials in tropical parasitic diseases
Handlos et al. [24] 35 trials in maternal and child health
Froud et al. [27] 23 trials in oral health
Ivers et al. [12] 300 trials of cluster design randomly selected
This review 73 trials in residential facilities for older people
h Calculated by us for consistency with other reports, as the reported 61% excludes
i This increases to 47% when those that did not report sample size calculations areA further possible limitation to our conclusion is the
choice of the year 2005 to dichotomise publication year,
and its use in analyses corresponding to the CONSORT
statement impact on quality. We recognise that the ex-
tended CONSORT guidelines were published in 2004
and that, due to time lags between submission of a
report and publication, a few of the reports we analysed
may not have been aware of these guidelines. However,
the guidelines were in development and draft versions of
them were common knowledge a few years prior to their
final appearance in print, so we consider this may not be
a severe limitation on validity.
Finally, authors may fail to report that their trials are
cluster-randomized; we may therefore have missed some
trials due to this.
Comparison with previous research
Proportions of trials in which clustering was accounted
for in the sample size and analysis (Table 4) were similar
to those for cluster randomised trials in all fields [12], and
in the fields of tropical disease and oncology [11,38], but
lower than in other areas [4,24,27]. Relative to previous re-
views, we judged that identification/recruitment bias was
possible in a lower percentage (7%) and unclear in a
higher percentage (32%) of our included trials [4,27].
Ours is not the first review to identify particularly poor
reporting of factors such as observed intra-cluster corre-
lation coefficients and cluster characteristics that have less
influence on the validity of the main trial analyses than on
their usefulness to practitioners, policy makers and future
researchers [4,10,12]. Overall, proportions adhering tocalculations and analysis in previous reviews
Years Clustering accounted for
In sample size In analysis
1979-1989 19% 50%
1990-1993 19% 57%
1975-1998 0% 58%
1973-2001 20% 37%
1997-2002 56% 92%
1997-2000 9% 59%
1998-2002 15% 54%
1983-2003 n/a 72%
2004-2005 62% 88%
2002-2006 24% 45%
1998-2007 29% 43%
1998-2008 71% 80%
2005-2009 65% 78%
2000-2008 33%h 70%
1993-2010 27% i 74%
those trials which did not report sample size calculations.
excluded.
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http://www.biomedcentral.com/1471-2288/13/127various criteria in our review were not dissimilar to pro-
portions in the recent review of cluster randomised trials
in all fields that used a similar set of quality criteria [40].
The effect of the presence of a statistician in the research
team on study quality supports previous research in the
context of individually randomised trials [15]. In contrast,
we found no evidence of an association between journal
endorsement of the 2004 extended CONSORT statement
and reporting quality, contrary to the findings of previous
research, which identified better reporting amongst ran-
domised controlled trials published in journals more
strongly promoting the original 1996 CONSORT state-
ment [16].
Interpretation
Our review covers a longer time period than some other
recent reviews of cluster randomised trials. Twentieth
century trials included in our review tended to be lower
quality with, for example, none accounting for clustering
in the sample size calculation. This may explain why our
results suggest an improvement over time in this cri-
terion when the review of cluster randomised trials in all
fields between 2000 and 2008 did not [12]. A further
explanation is that trends in one field may be masked
when trials from all fields are reviewed, particularly in a
research area such as cluster randomised trials in which
the number of studies is growing. Although the numbers
of trials included in our analyses preclude definitive con-
clusions, we hypothesise that improvements in reporting
of these trials have been taking place gradually since the
turn of the millennium when there was a proliferation of
books and journal articles relating to cluster randomised
trials, but at different rates in different fields, and the ex-
tended CONSORT statement has been a reinforcement
of that change rather than a precipitator. This is consis-
tent with similar phenomena of procedural or organi-
sational change taking place after individual behaviour
change seen in other contexts in society at large.
While published guidelines may have been successful
in effecting some change in reporting practices, it is
plausible that the presence of suitably qualified indi-
viduals on a research team exerts a greater influence on
trial design, conduct and analysis than written instruc-
tions to adhere to such guidelines. The latter may in-
fluence reporting more than they influence trial design.
Although we only explored the impact of the presence
of a statistician on three key methodological features, we
acknowledge that individuals with other types of exper-
tise may have a similar effect on key aspects of trials in
other areas.
Conclusions
Cluster randomised trials in residential facilities need im-
provement. Direct statistician involvement may improvethe methodological quality of cluster randomised trials
more than journal endorsement of the CONSORT state-
ment. Investigators should always involve a statistician in
their trial team and funders and journals should encou-
rage this.
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